At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
Overview
FAQ about ieCrowd
When was ieCrowd founded?
ieCrowd was founded in 2010.
How much funding has ieCrowd raised?
ieCrowd has raised $3.6M in total across 2 funding rounds.
What funding rounds has ieCrowd raised?
Parsers VC lists 2 funding rounds of ieCrowd, among them a funding round of $2.2M on Jun 19, 2014.
Is ieCrowd still active?
Yes, ieCrowd is active; its latest activity on Parsers VC dates from Jun 19, 2014.